Skip to main content
. 2021 Mar 25;16(8):2077–2086. doi: 10.1007/s11739-021-02718-8

Table 2.

Descriptive statistics stratified to the admission period

Demographic characteristics and source of admission Whole study period Pre-LD In-LD After-LD p value
Age 71 (60–79) 72 (60–80) 70 (62–79) 70 (58–79) 0.620
Female gender 260 (32.3) 110 (34.5) 56 (27.1) 94 (33.6) 0.173
Self-presentation to the emergency department 238 (29.6) 104 (32.8) 53 (25.6) 81 (29) 0.441
Admission from the emergency medical system 358 (44.6) 139 (43.8) 95 (45.9) 124 (44.4)
Direct outside or inside hospital transfer 207 (25.8) 74 (23.3) 54 (38.5) 74 (26.5)
Timing from symptom onset to hospitalization (only for STEMI)
0–3 h 131 (50.2) 56 (53.3) 38 (52.8) 37 (44) 0.12
4–6 h 36 (13.8) 15 (14.3) 11 (15.3) 10 (11.9)
6–12 h 36 (13.8) 14 (13.3) 13 (18.1) 9 (10.7)
 > 12 h 58 (22.2) 20 (19) 10 (13.9) 28 (33.3)
Comorbidities
Hypertension 562 (69.7) 226 (70.8) 148 (71.5) 188 (67.1) 0.501
Hyperlipidaemia 423 (52.5) 155 (48.6) 128 (61.8) 140 (50.2) 0.007
Diabetes not requiring insuline 176 (21.9) 65 (20.4) 49 (23.7) 62 (22.3) 0.657
Diabetes requiring insuline 71 (8.8) 31 (9.7) 15 (7.2) 25 (8.9) 0.612
Smokers 257 (31.9) 107 (33.5) 57 (27.5) 93 (33.2) 0.296
Familiar history of coronary artery disease 122 (15.1) 44 (13.8) 24 (11.6) 54 (19.3) 0.045
Chronic kidney disease 161 (20) 68 (21.3) 39 (18.8) 54 (19.3) 0.737
End stage chronic kidney disease needing renal replacement therapy 24 (3) 10 (3.1) 5 (2.4) 9 (3.2) 0.857
Coronary artery disease 215 (26.7) 88 (27.6) 63 (30.4) 64 (22.9) 0.156
History of heart failure 121 (15) 52 (16.3) 31 (15) 38 (13.6) 0.647
History of atrial fibrillation 136 (16.9) 54 (16.9) 40 (19.3) 42 (15.1) 0.462
Previous stroke 71 (8.8) 28 (8.8) 27 (13) 16 (5.7) 0.019
Chronic obstructive pulmonary disease 95 (11.8) 42 (13.2) 25 (12.1) 28 (10) 0.482
Peripheral artery disease 127 (15.8) 54 (16.9) 31 (15) 42 (15) 0.761
Anaemia 88 (10.9) 31 (9.7) 29 (14) 28 (10) 0.253
Malignancy 82 (10.2) 28 (8.8) 15 (7.2) 39 (13.9) 0.031
Neurological and/or psychiatric disorder 90 (11.2) 36 (11.3) 27 (13) 27 (9.6) 0.498
Charlson Comorbidity Index 4 (3–6) 5 (3–6) 4 (3–6) 4 (3–6) 0.823
In-hospital procedures
Coronary angiography 570 (71) 243 (76.4) 129 (62.6) 198 (71) 0.003
Percutaneous coronary intervention 425 (60.2) 170 (54.8) 108 (60) 147 (68.1) 0.01
Intra-aortic balloon pump 26 (3.2) 13 (4.1) 4 (1.9) 9 (3.2) 0.39
Pericardiocentesis 12 (1.5) 5 (1.6) 1 (0.5) 6 (2.2) 0.32
Temporary pacing 32 (4) 7 (2.2) 10 (4.8) 15 (5.4) 0.11
Central venous catheter insertion 126 (15.6) 42 (13.2) 45 (21.7) 39 (13.9) 0.02
Arterial catheter insertion 192 (23.8) 64 (20.1) 61 (29.5) 67 (23.9) 0.047
Non-invasive ventilation 71 (8.8) 27 (8.5) 16 (7.7) 28 (10) 0.66
Invasive ventilation 50 (6.2) 23 (7.2) 15 (7.2) 12 (4.3) 0.26
Haemodialysis 33 (4.2) 10 (3.1) 12 (5.8) 11 (3.9) 0.32

Differences among the three main admission periods, for the whole study population. Categorical variables are presented as absolute number and percentage value. Numeric data are expressed as mean (SD) or median (interquartile range [IQR]), as appropriate. A Chi-square test was performed for categorical variables, while a non-parametric analysis of variance (Kruskal–Wallis test) was used for comparison of continuous variables among the three groups

Pre-LD, in-LD and after-LD: before the lockdown, during the lockdown and after the lockdown period